ARCHIVES

NCI Budget of $1.4 Billion Seems Assured, Barring GRH Cut, Veto; Organ Systems Renewal Confirmed

This article is from The Cancer Letter archive.

Vol. 12 No. 40 | October 17, 1986

Download PDF Visit The Full Archive

Related Articles

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001